CLEE011012001- Adjuvant Wider
Study #CLEE011012001A phase IIIb study to characterize the effectiveness and safety of Adjuvant ribociclib in a wide patient population with HR+ HER2- early breast cancer
Interested in this trial? Email [email protected].